Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

iShares Nasdaq Biotechnology ETF (IBB)

Delayed Data
As of 4:00pm ET
 +2.79 / +0.85%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to track the investment results of the NASDAQ Biotechnology Index, which contains securities of companies listed on NASDAQ that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by Nasdaq, Inc. The fund generally invests at least 90% of its assets in securities of the index and in depositary receipts representing securities of the index. It may invest the remainder of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.

Rotational Shift Doesn't Explain Alergan Slide
Sep 19 / TheStreet.com - Paid Partner Content
Should You Keep Your Portfolio Healthy with Biotech ETFs?
Sep 12 / Zacks.com - Paid Partner Content
This Biotech Trend Could Indicate the Next 4-Year Bull Run
Sep 14 / GuruFocus News - Paid Partner Content


1 month+8.60% 3 years+6.38%
3 months+10.10% 5 years+18.32%
1 year+13.41% Since inception+7.60%
Data through 09/20/2017

Quote Details

Previous close$329.96
Open day’s range329.81 – 333.77
Net asset value (NAV)330.07 (09/19/2017)
Daily volume716,726
Average volume (3 months)1,083,597
Data as of 4:00pm ET, 09/20/2017

Peer Comparisonvs. Health ETFs

Performance 5-yr return+18.32%+17.39%
Expense Gross exp ratio0.47%1.33%
Risk 5 year sharpe ratio0.901.13
Net assets$9.9B$3.1B
Average market cap$20.3B$32.0B
Average P/E23.422.7
Dividend / Share--0.28%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Healthcare 99.91%
Business service 0.09%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
GILD Gilead Sciences8.81%
BIIB Biogen8.72%
CELG Celgene8.29%
AMGN Amgen7.82%
REGN Regeneron Pharmaceuticals7.09%
ALXN Alexion Pharmaceuticals Inc4.50%
VRTX Vertex Pharmaceuticals Inc4.43%
ILMN Illumina Inc3.93%
INCY Incyte Corp3.63%
MYL Mylan NV2.37%